Your medical briefing

Stay current.
Stay focused.

Research, guidelines, and safety alerts for your specialty.

All specialties Internal Medicine Family Medicine Pediatrics Cardiology Oncology Endocrinology Surgery

Pediatric Emergency Medicine

Recent updates in Pediatric Emergency Medicine from the last 30 days.

AllAll updates Research Guidelines Safety alerts

A retrospective study using National Trauma Data Bank records from 2017 to 2023 examined head CT use in children with isolated mild traumatic brain injury across adult, pediatric, and mixed hospitals. Overall CT use remained high, ranging from 43.5% to 51.5% over the study period, with adult hospitals showing the highest rate (59.5%) compared to mixed (44.0%) and pediatric hospitals (38.8%). The authors state these findings reveal persistent gaps in guideline adoption and call for research into barriers driving this variability.

Stay current.
Stay focused.

Pediatric Emergency Medicine

Pediatric Mild Brain Injury CT Rates Vary by Hospital Type

Case series highlights delayed diagnosis of hereditary TTP in newborns

Routine eye exams rarely find cCMV-related findings in screened infants

Hybrid cCMV screening program increased case detection 2.5-fold

AAP Clinical Report Updates Guidance on Congenital CMV Infection

Retrospective study details ED visits for pediatric epidermolysis bullosa

Point-of-care alert sustained shorter antibiotic courses for pediatric SSTI

Class I recall: Baxter Healthcare Corporation: Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporat

Pediatric Sepsis Mortality Varies Widely by US Region

QI project raises balanced fluid use in pediatric sepsis care

Pediatric firearm ED visits nearly doubled from 2016 to 2023

Class II recall: Baxter Healthcare Corporation: Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Cont

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Sin

Class I recall: OPTIMAL BALANCE PHARMACY: Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutath

Class I recall: Baxter Healthcare Corporation: 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 u

Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in G

Class II recall: Baxter Healthcare Corporation: Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/m

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count b

Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx On

Class II recall: Mallinckrodt Hospital Products Inc.: Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Onl

Class I recall: Fresenius Kabi USA, LLC: Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Onl

ACEP Approves Consensus Guidelines on Unscheduled Procedural Sedation

Manual detorsion by ED physicians cut testicular ischemia time by 105 minutes

Stay current. Stay focused.

Stay current.
Stay focused.